An open-label single-center study to assess the safety and efficacy of dose escalation of alefacept 15 mg IM for 6 weeks followed by 6 weeks of 30 mg IM in patients with moderate to severe chronic plaque psoriasis

• Book ID: 116580433
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 52 KB
• Volume: 52
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2004.10.720